Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06696157 · ClinicalTrials.gov registry record · NA

EXPANDED SCOPE for Parent Grant Entitled, "Peer Recovery Support Services for Individuals in Recovery Residences on MOUD"

A NA study of Opioid Use Disorder, sponsored by Potomac Health Foundations.

Recruiting
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT06696157 is a NA study of Opioid Use Disorder that is actively recruiting participants, run by Potomac Health Foundations. The registered enrollment target is 35 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06696157, a NA study of Opioid Use Disorder, is actively recruiting participants, sponsored by Potomac Health Foundations.

RECRUITING
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

The United States is experiencing an unprecedented opioid epidemic. Medications for opioid use disorder (MOUD), such as methadone, buprenorphine, and extended-release naltrexone, are the recommended standard of care. There are, however, many barriers to MOUD initiation so that only a minority of individuals who could benefit from MOUD treatment ever receive it. Even among individuals presenting to a residential level of specialty SUD care, only about 20% of individuals with OUD initiate MOUD leaving them at a higher risk of opioid relapse, overdose, and death. Thus, the goal of this expansion of scope pilot study is to address this gap by modifying our currently R34-funded intervention (RFA-DA-22-034; Project # 1R34DA057627-01) that leverages the impact of peer recovery support services (PRSS) to promote MOUD initiation. Although PRSS for MOUD initiation shows promise within emergency department settings, the impact of PRSS for MOUD initiation within residential substance use disorder (SUD) settings is unknown. Residential SUD settings are an ideal opportunity to initiate medications because individuals with OUD typically have access to medically-managed withdrawal and the opportunity to learn about and initiate onto MOUD. This PRSS intervention has already been developed in the R34 parent grant to promote MOUD retention, and in this expanded scope project it will be further adapted and tested with a small pilot sample of individuals (N = 10-20) who are further upstream in the cascade of care (COC). Peers will be embedded within the inpatient program unit where the study will take place. Early into their inpatient stay and before MOUD initiation occurs, peers will introduce themselves to patients and provide motivational enhancements for MOUD initiation and inpatient treatment retention through a variety of strategies. Peer strategies will be based on the existing PRSS intervention in the parent grant and may include exploration of MOUD knowledge and attitudes, disc

Conditions Studied

Interventions

  • BEHAVIORAL PRSS intervention for MOUD initiation

Study Locations (1)

Maryland

  • Maryland Treatment Centers - Baltimore

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2024-12-01
Est. Completion 2026-09-29
Phase NA

Sponsor

Potomac Health Foundations

8 total trials

What the Registry Record Tells You About NCT06696157

The ClinicalTrials.gov registry entry for NCT06696157 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Potomac Health Foundations, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which PRSS intervention for MOUD initiation is the first listed.

NCT06696157 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06696157 about?

NCT06696157 is a clinical study titled "EXPANDED SCOPE for Parent Grant Entitled, "Peer Recovery Support Services for Individuals in Recovery Residences on MOUD"". The United States is experiencing an unprecedented opioid epidemic. Medications for opioid use disorder (MOUD), such as methadone, buprenorphine, and extended-release naltrexone, are the recommended standard of care. There are, however, many barriers to MOUD initiation so that only a minority of ind...

What is the current status of trial NCT06696157?

This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2024-12-01. Estimated completion is 2026-09-29.

What conditions does trial NCT06696157 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT06696157?

The interventions under investigation include: PRSS intervention for MOUD initiation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06696157?

This trial is sponsored by Potomac Health Foundations, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06696157 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.